[F-18]Flornaptitril

N/A

Report date: 2025/11/26 17:11:19

Base Information

Drug Name[F-18]Flornaptitril

Drug Alias Name[F-18]FDDNPF-18-FNT-PET

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FDiagnostic agent (In vivo) > Radionuclide Imaging agent +[4]

Mechanisms of ActionBeta amyloid A4 protein bindersMicrotubule-associated protein tau binders

TargetsBeta amyloid A4 proteinMicrotubule-associated protein tau

Therapy Area/IndicationsAlzheimer DiseaseChronic Traumatic Encephalopathy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of California At Los Angeles

China Registration ClassN/A

Develop Information

Active CompaniesCereMark Pharma LLC

Inactive CompaniesN/A

Active IndicationsAlzheimer DiseaseChronic Traumatic Encephalopathy

Inactive IndicationsN/A

Other Information

ATC CodeN/A